Cite
HARVARD Citation
Lambertini, M. et al. (n.d.). 90OThe role of dose-dense (DD) adjuvant chemotherapy (CT) in HER2-positive (HER2+) early breast cancer (BC) patients (pts) before and after the introduction of trastuzumab (T): Exploratory analysis of the GIM2 trial. Annals of oncology. p. . [Online].